Capstone Investment Advisors
CELU icon

Capstone Investment Advisors’s Celularity CELU Stock Holding History

Capstone Investment Advisors’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,420
Closed -$124K – 1857
2022
Q1 		$124K Buy
+1,420
New +$85.1K ﹤0.01% 1824

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return

Capstone Investment Advisors's CELU Position: Q2 2022 in Review

Capstone Investment Advisors sold out of Celularity (CELU) in Q2 2022, closing a stake of 1,420 shares — an estimated $124K sold.

Capstone Investment Advisors first reported a position in CELU in Q1 2022 and held it in 1 quarter. The position peaked at $124K in Q1 2022. 66 funds tracked by Wall St. Rank hold CELU as of Q2 2022.

  • Capstone Investment Advisors reported no remaining Celularity position as of Q2 2022 after selling out during the quarter.
  • Capstone Investment Advisors sold 1,420 Celularity shares in Q2 2022, an estimated $124K.
  • Capstone Investment Advisors first reported a position in Celularity in Q1 2022 and held it in 1 quarter.
  • Capstone Investment Advisors's Celularity position peaked at $124K in Q1 2022.
  • 66 funds tracked by Wall St. Rank held Celularity as of Q2 2022.

Based on Capstone Investment Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.